An integrated strategy of multiplex qPCR and BclA gene length polymorphism analysis for differentiating Bacillus anthracis wild-type and vaccine strains

ABSTRACT A combined molecular strategy was developed to accurately differentiate wild-type and vaccine strains of Bacillus anthracis . This approach integrates a multiplex TaqMan qPCR assay targeting the BclA , sap , and cap genes with conventional PCR analysis of BclA fragment length polymorphism. The qPCR assay demonstrated high specificity, with no cross-reactivity against other common pathogens, and exhibited a consistent limit of detection of 2.11 × 10 1 copies/μL (Cq < 35) for all three targets. Excellent repeatability was confirmed, with intra- and inter-assay coefficients of variation below 1.96% and 3.06%, respectively. Validation using 19 wild-type strains revealed two distinct qPCR profiles, and all wild-type strains were conclusively differentiated from the capsule-producing Chinese vaccine strain II and the acapsular Sterne strain by their characteristic BclA amplicon sizes. Through simulation PCR validation of common global canSNP genotyping (groups A, B, and C), it is possible to distinguish between wild-type and vaccine strains in China. This integrated “multiplex qPCR–BclA length analysis” protocol provides a reliable, sensitive, and specific tool for the precise detection and differentiation of B. anthracis strains in China. IMPORTANCE Anthrax, which is caused by the bacterium B. anthracis , remains a serious zoonotic disease. Its effective surveillance relies on precise strain identification. Currently, it is challenging to rapidly and accurately distinguish wild-type strains from vaccine strains, which hinders outbreak investigation and response. This study develops a novel molecular strategy combining multiple genetic targets to solve this critical diagnostic problem. The new method provides a reliable tool for strain differentiation, directly supporting accurate source tracing and informed decision-making during anthrax outbreaks. By improving diagnostic precision, this work contributes to strengthening public and veterinary health defenses against this persistent threat.

Authors

Institutions

Publication Details

Journal
Microbiology Spectrum
Published
2026-09-01
DOI
https://doi.org/10.1128/spectrum.00192-26
Primary Topic
Bacillus and Francisella bacterial research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An integrated strategy of multiplex qPCR and BclA gene length polymorphism analysis for differentiating Bacillus anthracis wild-type and vaccine strains

Lingwei Zhu, Yanfang Li, Yan Liang, Yonggang Qu et al.
Microbiology Spectrum
Bacillus and Francisella bacterial research
article

An integrated strategy of multiplex qPCR and BclA gene length polymorphism analysis for differentiating Bacillus anthracis wild-type and vaccine strains

Lingwei Zhu, Yanfang Li, Yan Liang, Yonggang Qu, Jiaqi Yang, Bing Liang
article en

Abstract

ABSTRACT A combined molecular strategy was developed to accurately differentiate wild-type and vaccine strains of Bacillus anthracis . This approach integrates a multiplex TaqMan qPCR assay targeting the BclA , sap , and cap genes with conventional PCR analysis of BclA fragment length polymorphism. The qPCR assay demonstrated high specificity, with no cross-reactivity against other common pathogens, and exhibited a consistent limit of detection of 2.11 × 10 1 copies/μL (Cq < 35) for all three targets. Excellent repeatability was confirmed, with intra- and inter-assay coefficients of variation below 1.96% and 3.06%, respectively. Validation using 19 wild-type strains revealed two distinct qPCR profiles, and all wild-type strains were conclusively differentiated from the capsule-producing Chinese vaccine strain II and the acapsular Sterne strain by their characteristic BclA amplicon sizes. Through simulation PCR validation of common global canSNP genotyping (groups A, B, and C), it is possible to distinguish between wild-type and vaccine strains in China. This integrated “multiplex qPCR–BclA length analysis” protocol provides a reliable, sensitive, and specific tool for the precise detection and differentiation of B. anthracis strains in China. IMPORTANCE Anthrax, which is caused by the bacterium B. anthracis , remains a serious zoonotic disease. Its effective surveillance relies on precise strain identification. Currently, it is challenging to rapidly and accurately distinguish wild-type strains from vaccine strains, which hinders outbreak investigation and response. This study develops a novel molecular strategy combining multiple genetic targets to solve this critical diagnostic problem. The new method provides a reliable tool for strain differentiation, directly supporting accurate source tracing and informed decision-making during anthrax outbreaks. By improving diagnostic precision, this work contributes to strengthening public and veterinary health defenses against this persistent threat.

Microbiology Spectrum
Shihezi University (CN), Chinese Academy of Agricultural Sciences (CN)
National Natural Science Foundation of China, Shihezi University
Peace, Justice and strong institutions
Openalex Percentile: Top 18%
Bacillus and Francisella bacterial research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.